Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
7.94
+0.48 (6.43%)
At close: May 12, 2025, 4:00 PM
8.14
+0.20 (2.52%)
Pre-market: May 13, 2025, 4:05 AM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $690.87 million as of May 13, 2025. Its market cap has decreased by -18.90% in one year.
Market Cap
690.87M
Enterprise Value
373.55M
1-Year Change
-18.90%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $690.87M, an increase of 520.22%. That is a compound annual growth rate of 48.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 649.11M | -2.08% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |